Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory and clinical considerations for biosimilar oncology drugs.
Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Qureshi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO. Bennett CL, et al. Among authors: sartor o. Lancet Oncol. 2014 Dec;15(13):e594-e605. doi: 10.1016/S1470-2045(14)70365-1. Epub 2014 Nov 24. Lancet Oncol. 2014. PMID: 25456378 Free PMC article. Review.
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Ladewski LA, et al. Among authors: sartor o. J Clin Oncol. 2003 Oct 15;21(20):3859-66. doi: 10.1200/JCO.2003.04.537. J Clin Oncol. 2003. PMID: 14551305
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB 3rd, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL. Richey EA, et al. Among authors: sartor o. J Clin Oncol. 2009 Sep 10;27(26):4398-405. doi: 10.1200/JCO.2008.21.1961. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636013 Free PMC article.
Reassessments of ESAs for cancer treatment in the US and Europe.
Bennett CL, McKoy JM, Henke M, Silver SM, MacDougall IC, Birgegård G, Luminari S, Casadevall N, Schellekens H, Sartor O, Lai SY, Armitage JO. Bennett CL, et al. Among authors: sartor o. Oncology (Williston Park). 2010 Mar;24(3):260-8. Oncology (Williston Park). 2010. PMID: 20394138 Free article.
Enforcement actions involving Medicaid fraud and abuse, 1996-2009.
Qureshi ZP, Liu Y, Sartor O, Chu YH, Bennett CL. Qureshi ZP, et al. Among authors: sartor o. Arch Intern Med. 2011 Apr 25;171(8):785-7. doi: 10.1001/archinternmed.2011.142. Arch Intern Med. 2011. PMID: 21518950 No abstract available.
Pharmaceutical fraud and abuse in the United States, 1996-2010.
Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL. Qureshi ZP, et al. Among authors: sartor o. Arch Intern Med. 2011 Sep 12;171(16):1503-6. doi: 10.1001/archinternmed.2011.397. Arch Intern Med. 2011. PMID: 21911639 No abstract available.
503 results